Metastatic Prostate Cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate Cancer

BACKGROUND: The European Randomized study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cancer (PC) mortality and a 1·6-fold increase in PC incidence with PSA-based screening (at 13 years of follow-up). We evaluated PC incidence by risk category at diagnosis across t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur Urol
Main Authors: Buzzoni, Carlotta, Auvinen, Anssi, Roobol, Monique J, Carlsson, Sigrid, Moss, Sue M, Puliti, Donella, de Koning, Harry J, Bangma, Chris H, Denis, Louis J, Kwiatkowski, Maciej, Lujan, Marcos, Nelen, Vera, Paez, Alvaro, Randazzo, Marco, Rebillard, Xavier, Tammela T, Teuvo LJ, Villers, Arnauld, Hugosson, Jonas, Schröder, Fritz H, Zappa, Marco
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982869/
https://ncbi.nlm.nih.gov/pubmed/25791513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2015.02.042
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki